DSpace Repository

Current consensus guidelines for treatment of neurocysticercosis.

Show simple item record

dc.contributor.author García Lescano, Héctor Hugo
dc.contributor.author Evans, Carlton Anthony William
dc.contributor.author Nash, Theodore E.
dc.contributor.author Takayanagui, Osvaldo M.
dc.contributor.author White, A. Clinton
dc.contributor.author Botero, David
dc.contributor.author Rajshekhar, Vedantam
dc.contributor.author Tsang, Victor C. W.
dc.contributor.author Schantz, Peter M.
dc.contributor.author Allan, James C.
dc.contributor.author Flisser, Ana
dc.contributor.author Correa, Dolores
dc.contributor.author Sarti, Elsa
dc.contributor.author Friedland, Jon S.
dc.contributor.author Martinez, S. Manuel
dc.contributor.author Gonzalez Zariquiey, Armando Emiliano
dc.contributor.author Gilman, Robert Hugh
dc.contributor.author Del Brutto, Oscar H.
dc.date.accessioned 2022-10-25T19:54:09Z
dc.date.available 2022-10-25T19:54:09Z
dc.date.issued 2002
dc.identifier.uri https://hdl.handle.net/20.500.12866/12453
dc.description.abstract Taenia solium neurocysticercosis is a common cause of epileptic seizures and other neurological morbidity in most developing countries. It is also an increasingly common diagnosis in industrialized countries because of immigration from areas where it is endemic. Its clinical manifestations are highly variable and depend on the number, stage, and size of the lesions and the host's immune response. In part due to this variability, major discrepancies exist in the treatment of neurocysticercosis. A panel of experts in taeniasis/cysticercosis discussed the evidence on treatment of neurocysticercosis for each clinical presentation, and we present the panel's consensus and areas of disagreement. Overall, four general recommendations were made: (i) individualize therapeutic decisions, including whether to use antiparasitic drugs, based on the number, location, and viability of the parasites within the nervous system; (ii) actively manage growing cysticerci either with antiparasitic drugs or surgical excision; (iii) prioritize the management of intracranial hypertension secondary to neurocysticercosis before considering any other form of therapy; and (iv) manage seizures as done for seizures due to other causes of secondary seizures (remote symptomatic seizures) because they are due to an organic focus that has been present for a long time. en_US
dc.language.iso eng
dc.publisher American Society for Microbiology
dc.relation.ispartofseries Clinical Microbiology Reviews
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Health Planning Guideline en_US
dc.subject Neurocysticercosis en_US
dc.title Current consensus guidelines for treatment of neurocysticercosis. en_US
dc.type info:eu-repo/semantics/review
dc.identifier.doi https://doi.org/10.1128/CMR.15.4.747-756.2002
dc.relation.issn 1098-6618

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

info:eu-repo/semantics/restrictedAccess Except where otherwise noted, this item's license is described as info:eu-repo/semantics/restrictedAccess

Search DSpace


My Account